Compare NUTX & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUTX | SEER |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | 944 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 108.0M |
| IPO Year | 2009 | 2020 |
| Metric | NUTX | SEER |
|---|---|---|
| Price | $200.24 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $252.50 | N/A |
| AVG Volume (30 Days) | 116.9K | ★ 188.3K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.93 | ★ 9.40 |
| EPS | ★ 15.87 | N/A |
| Revenue | ★ $875,257,000.00 | $16,578,000.00 |
| Revenue This Year | $6.12 | $2.14 |
| Revenue Next Year | $4.04 | $25.90 |
| P/E Ratio | $12.46 | ★ N/A |
| Revenue Growth | ★ 82.36 | 16.99 |
| 52 Week Low | $83.99 | $1.55 |
| 52 Week High | $204.00 | $2.41 |
| Indicator | NUTX | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 59.05 | 37.71 |
| Support Level | $142.71 | $1.83 |
| Resistance Level | $196.41 | $1.99 |
| Average True Range (ATR) | 9.72 | 0.04 |
| MACD | -0.41 | -0.01 |
| Stochastic Oscillator | 78.74 | 6.62 |
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.